Mark Johnson to Gelatinases
This is a "connection" page, showing publications Mark Johnson has written about Gelatinases.
Connection Strength
0.023
-
Low JA, Johnson MD, Bone EA, Dickson RB. The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice. Clin Cancer Res. 1996 Jul; 2(7):1207-14.
Score: 0.008
-
Kawamata H, Kawai K, Kameyama S, Johnson MD, Stetler-Stevenson WG, Oyasu R. Over-expression of tissue inhibitor of matrix metalloproteinases (TIMP1 and TIMP2) suppresses extravasation of pulmonary metastasis of a rat bladder carcinoma. Int J Cancer. 1995 Nov 27; 63(5):680-7.
Score: 0.008
-
Thompson EW, Br?nner N, Torri J, Johnson MD, Boulay V, Wright A, Lippman ME, Steeg PS, Clarke R. The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells. Clin Exp Metastasis. 1993 Jan; 11(1):15-26.
Score: 0.007